← Leaderboards
John J Rublein
University Of North Carolina Chapel Hill
$1,698
Attributed
$1,698
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,698 · 1
By mechanism
M01$1,698 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of North Carolina Chapel Hill
Same institution · by research overlap
- Charles Michael Van Der Horst$17,688,631
- Wilma J Lim$2,704,196
- Colin D Hall$6,763,979
- Michael J Fried$0
- Christopher D Pilcher$6,871,284
Others in their field
Top investigators on “Reverse Transcriptase Inhibitors”
- Constance Ann Benson · University Of California, San Diego$66,171,637
- Robert M. Grant · J. David Gladstone Institutes$32,696,904
- David Heimbrook · Leidos Biomedical Research, Inc.$17,920,785
- Jerold Chun · Sanford Burnham Prebys Medical Discovery Institute$14,663,617
- Edward V Arnold · Rutgers Biomedical And Health Sciences$13,985,842
- Karen S Anderson · Yale University$13,953,288
Research focus
Reverse Transcriptase InhibitorsProtease InhibitorAntiviral AgentsClinical ResearchCombination ChemotherapyDrug Screening /EvaluationHiv InfectionsHuman SubjectHuman Therapy EvaluationAids TherapyAntiaids AgentMicroorganism Disease ChemotherapyZidovudineLamivudineStavudineOmeprazoleIndinavirPatient Oriented Research
Grant awards (5)
Effect of Omeprazole on the Pharmacokinetics of Indinavir$1,698
M01 · FY2004 · RR
FTC VS LAMIVUDINE IN PTS ON TRIPLE ANTIRETROVIRAL THERAPY$0
M01 · FY2000 · RR
FTC VS LAMIVUDINE IN PTS ON TRIPLE ANTIRETROVIRAL THERAPY$0
M01 · FY2000 · RR
FTC VS LAMIVUDINE IN PTS ON TRIPLE ANTIRETROVIRAL THERAPY$0
M01 · FY2000 · RR
FTC VS LAMIVUDINE IN PTS ON TRIPLE ANTIRETROVIRAL THERAPY$0
M01 · FY2000 · RR